BZPEERPapers, people, evidence and research pathsDiscover
Research tools
Network
Opportunities
Account
Source author record
Yihui Liu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.
Catalog footprint
Research graph
Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.
BZPEER is loading the nearby papers, people, topics and institutions for this page.
Published work
Adverse drug reaction (ADR) is widely concerned for public health issue. In this study we propose an original approach to detect the ADRs using feature matrix and feature selection. The experiments are carried out on the drug Aspirin. Major side effects for the drug are detected and better performance is achieved compared to other computerized methods. The detected ADRs are based on the computerized method, further investigation is needed.
Adverse drug reactions (ADR) are widely concerning for public health issue. In this study we propose an original approach to detect ADRs using a feature matrix and feature selection. The experiments are carried out on the drug Simvastatin. Major side effects for the drug are detected and better performance is achieved compared to other computerized methods. Because currently the detected ADRs are based solely on computerized methods, further expert investigation is needed.
Adverse drug reaction (ADR) is widely concerned for public health issue. ADRs are one of most common causes to withdraw some drugs from market. Prescription event monitoring (PEM) is an important approach to detect the adverse drug reactions. The main problem to deal with this method is how to automatically extract the medical events or side effects from high-throughput medical events, which are collected from day to day clinical practice. In this study we propose a novel concept of feature matrix to detect the ADRs. Feature matrix, which is extracted from big medical data from The Health Improvement Network (THIN) database, is created to characterize the medical events for the patients who take drugs. Feature matrix builds the foundation for the irregular and big medical data. Then feature selection methods are performed on feature matrix to detect the significant features. Finally the ADRs can be located based on the significant features. The experiments are carried out on three drugs: Atorvastatin, Alendronate, and Metoclopramide. Major side effects for each drug are detected and better performance is achieved compared to other computerized methods. The detected ADRs are based on computerized methods, further investigation is needed.
Adverse drug reaction (ADR) is widely concerned for public health issue. In this study we propose an original approach to detect the ADRs using feature matrix and feature selection. The experiments are carried out on the drug Simvastatin. Major side effects for the drug are detected and better performance is achieved compared to other computerized methods. The detected ADRs are based on the computerized method, further investigation is needed.
Adverse drug reactions (ADRs) are big concern for public health. ADRs are one of most common causes to withdraw some drugs from markets. Now two major methods for detecting ADRs are spontaneous reporting system (SRS), and prescription event monitoring (PEM). The World Health Organization (WHO) defines a signal in pharmacovigilance as "any reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously". For spontaneous reporting systems, many machine learning methods are used to detect ADRs, such as Bayesian confidence propagation neural network (BCPNN), decision support methods, genetic algorithms, knowledge based approaches, etc. One limitation is the reporting mechanism to submit ADR reports, which has serious underreporting and is not able to accurately quantify the corresponding risk. Another limitation is hard to detect ADRs with small number of occurrences of each drug-event association in the database. In this paper we propose feature selection approach to detect ADRs from The Health Improvement Network (THIN) database. First a feature matrix, which represents the medical events for the patients before and after taking drugs, is created by linking patients' prescriptions and corresponding medical events together. Then significant features are selected based on feature selection methods, comparing the feature matrix before patients take drugs with one after patients take drugs. Finally the significant ADRs can be detected from thousands of medical events based on corresponding features. Experiments are carried out on the drug Atorvastatin. Good performance is achieved.
In this study we propose a novel method to successfully detect the ADRs using feature matrix and feature selection. A feature matrix, which characterizes the medical events before patients take drugs or after patients take drugs, is created from THIN database. The feature selection method of Student's t-test is used to detect the significant features from thousands of medical events. The significant ADRs, which are corresponding to significant features, are detected. Experiments are performed on the drug Pioglitazone. Compared to other computerized methods, our proposed method achieves good performance.
Adverse drug reaction (ADR) is widely concerned for public health issue. ADRs are one of most common causes to withdraw some drugs from market. Prescription event monitoring (PEM) is an important approach to detect the adverse drug reactions. The main problem to deal with this method is how to automatically extract the medical events or side effects from high-throughput medical data, which are collected from day to day clinical practice. In this study we propose an original approach to detect the ADRs using feature matrix and feature selection. The experiments are carried out on the drug Pravastatin. Major side effects for the drug are detected. The detected ADRs are based on computerized method, further investigation is needed.
Biomarkers which predict patient's survival can play an important role in medical diagnosis and treatment. How to select the significant biomarkers from hundreds of protein markers is a key step in survival analysis. In this paper a novel method is proposed to detect the prognostic biomarkers of survival in colorectal cancer patients using wavelet analysis, genetic algorithm, and Bayes classifier. One dimensional discrete wavelet transform (DWT) is normally used to reduce the dimensionality of biomedical data. In this study one dimensional continuous wavelet transform (CWT) was proposed to extract the features of colorectal cancer data. One dimensional CWT has no ability to reduce dimensionality of data, but captures the missing features of DWT, and is complementary part of DWT. Genetic algorithm was performed on extracted wavelet coefficients to select the optimized features, using Bayes classifier to build its fitness function. The corresponding protein markers were located based on the position of optimized features. Kaplan-Meier curve and Cox regression model were used to evaluate the performance of selected biomarkers. Experiments were conducted on colorectal cancer dataset and several significant biomarkers were detected. A new protein biomarker CD46 was found to significantly associate with survival time.